← All indications
Graves Ophthalmopathy
An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
Drugs by status
Approved for this indication (1)
Phase 4 trials (21)
Phase 3 trials (22)
Phase 2 trials (14)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (16)
- Allergan
- Horizon Therapeutics, LLC
- Region Skane
- Medical University of Warsaw
- Stanford University
- University of Pisa
- University of Toronto
- Yonsei University
- Cardiff University
- Dalian Medical University
- University of British Columbia
- University of California, Los Angeles
- University of Ankara
- Jiao Tong University
- Karolinska Institute
- University of Gothenburg
Organization Involved with Phase 3 Indications (16)
- Horizon Pharma
- National Center for Research Resources (NCRR)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Central South University
- Cedars-Sinai Medical Center
- Lund University
- Mayo Clinic
- Tel Aviv University
- Xiamen University
- University of Vienna
- University of Santiago
- Isfahan University
- Sun Yat-Sen University
- Henan Medical University
- Centro Oftalmológico Moreiras
- Johannes Gutenburg University
Organization Involved with Phase 2 Indications (19)
- Regeneron
- Ipsen
- GlaxoSmithKline
- River Vision Development Corporation
- Silkiss, Rona Z., M.D., FACS
- Cornell University
- Harvard University
- Johns Hopkins University
- Sheffield Hallam University
- University of Michigan
- University of Milan
- University of Southern Denmark
- University of California, San Francisco
- Zhongsh Ophthalmic Center
- Technion University
- University of Duisburg-Essen
- Bankura Sammilani Medical College
- Cultech Ltd,
- Immunovant Sciences GmbH
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (11)
- Barwon Health
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Singapore National Eye Centre
- University of Melbourne
- University of Sydney
- University of Valencia
- Columbia University
- Emek Medical Center
- International Thyroid Eye Disease Society
- National Health and Medical Research Council, Australia
- International Stem Cell Forum